Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Beacon Medcare (Hk) Limited currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, PROSSER, ALISSA J, who is also the busiest examiner for the portfolio. The concentration of work is further reflected by the involvement of a distinct art unit. For practitioners, this indicates a focused prosecution pipeline where all current activity is consolidated under the assigned examiner and art unit.
This lack of examiner diversity means that the company's immediate patent prospects in this sector are tied to the specific interpretations of the assigned individual. Navigating the art unit requires a strategy tailored to its specific examination culture, as there are no other pending matters to provide a broader perspective on current USPTO trends for this portfolio. The alignment of the busiest examiner's workload with the total pending actions confirms that there is no secondary activity currently requiring attention.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PROSSER, ALISSA J | 1 | 15.7% | +11.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18741818 | COMPOSITION FOR PURIFICATION OF BIOFLUIDS | PROSSER, ALISSA J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18741818 | COMPOSITION FOR PURIFICATION OF BIOFLUIDS | PROSSER, ALISSA J | — |
| Art Unit | Apps |
|---|---|
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18741818 | COMPOSITION FOR PURIFICATION OF BIOFLUIDS | PROSSER, ALISSA J | 1619 | §103§112Other | Non-Final OA | — | Pending | Jun 13, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial